Go Symbol Lookup
Loading...

St. Jude Medical Inc

More

  • Early Glance: Medical Devices companies Thursday, 16 May 2013 | 10:34 AM ET

    Allergan fell $2.36 or 2.3 percent, to $100.46. Baxter International Inc. fell$. 05 or. 1 percent, to $70.50. Johnson& Johnson fell$. 38 or. 4 percent, to $87.26.

  • Final Glance: Medical Devices companies Wednesday, 15 May 2013 | 6:02 PM ET

    Allergan fell$. 96 or. 9 percent, to $102.82. Baxter International Inc. rose$. 06 or. 1 percent, to $70.55. Boston Scientific Corp. rose$. 40 or 4.6 percent, to $9.10.

  • Midday Glance: Medical Devices companies Wednesday, 15 May 2013 | 1:26 PM ET

    Allergan rose$. 11 or. 1 percent, to $103.89. Baxter International Inc. rose$. 02 or percent, to $70.51. Boston Scientific Corp. rose$. 30 or 3.4 percent, to $9.00.

  • Early Glance: Medical Devices companies Wednesday, 15 May 2013 | 10:24 AM ET

    Allergan fell$. 56 or. 5 percent, to $103.22. Baxter International Inc. fell$. 03 or percent, to $70.46. Boston Scientific Corp. rose$. 20 or 2.3 percent, to $8.90.

  • Final Glance: Medical Devices companies Tuesday, 14 May 2013 | 6:02 PM ET

    Allergan fell$. 08 or. 1 percent, to $103.78. Baxter International Inc. rose$. 03 or percent, to $70.49. Boston Scientific Corp. rose$. 05 or. 6 percent, to $8.70.

  • Midday Glance: Medical Devices companies Tuesday, 14 May 2013 | 2:11 PM ET

    Baxter International Inc. rose$. 39 or. 6 percent, to $70.85. Boston Scientific Corp. fell$. 02 or. 2 percent, to $8.63. Johnson& Johnson rose$. 84 or 1.0 percent, to $86.69.

  • Early Glance: Medical Devices companies Tuesday, 14 May 2013 | 10:37 AM ET

    Allergan fell$. 36 or. 3 percent, to $103.50. Baxter International Inc. rose$. 33 or. 5 percent, to $70.79. Boston Scientific Corp. rose$. 01 or. 1 percent, to $8.66.

  • Final Glance: Medical Devices companies Monday, 13 May 2013 | 6:02 PM ET

    Allergan fell$. 32 or. 3 percent, to $103.86. Baxter International Inc. fell$. 30 or. 4 percent, to $70.46. Boston Scientific Corp. rose$. 20 or 2.4 percent, to $8.65.

  • Midday Glance: Medical Devices companies Monday, 13 May 2013 | 1:18 PM ET

    Allergan fell$. 18 or. 2 percent, to $104.00. Baxter International Inc. fell$. 03 or percent, to $70.74. Boston Scientific Corp. rose$. 29 or 3.4 percent, to $8.74.

  • Early Glance: Medical Devices companies Monday, 13 May 2013 | 10:22 AM ET

    Allergan fell$. 37 or. 4 percent, to $103.82. Baxter International Inc. fell$. 34 or. 5 percent, to $70.42. Medtronic fell$. 02 or percent, to $49.15.

  • April 30- St. Jude Medical Inc:. *Announces ce mark and launch of first quadripolar crt pacemaker. *Says the allure quadra crt-p device is currently not approved for use in the.

  • April 26- St. James's Place:. *Numis raises target price to 610 p from 580 p; rating add. Reuters Station users, click. 1580 (; ().

  • BRIEF-St. James's Place first quarter sales rise 31 pct Thursday, 25 Apr 2013 | 2:06 AM ET

    LONDON, April 25- St. James's Place PLC:. *Total new business on an annual premium equivalent basis of 199.2. *Net inflow of funds under management of 947 million.

  • In the U.S. volumes at hospitals, in-patient and out-patient are soft, "said David Heupel, senior healthcare analyst at Thrivent Investment Management.

  • UPDATE 1-St. Jude Medical posts higher quarterly profit Wednesday, 17 Apr 2013 | 7:54 AM ET

    April 17- Medical device maker St. Jude Medical Inc said on Wednesday its quarterly earnings rose as expenses fell. First-quarter net earnings were $222 million, or 78 cents per diluted share, compared with $212 million, or 67 cents per diluted share, in the year ago period.

  • St. Jude Medical post higher quarterly profit Wednesday, 17 Apr 2013 | 7:42 AM ET

    First-quarter net earnings were $222 million, or 78 cents per diluted share, compared with $212 million, or 67 cents per diluted share, in the year ago period.

  • April 17- Medical device maker St. Jude Medical Inc said on Wednesday first-quarter profit rose as lower expenses outweighed a decline in sales but warned that full-year revenue will be hurt by foreign exchange effects.

  • Fight or Flight: Get Ready for the Earnings Crush Sunday, 14 Apr 2013 | 6:38 PM ET

    Earnings season kicks into high gear in the week ahead. Plus, at least 10 Fed speeches. How risk-averse are investors? Oh, this is going to put them to the test. Rest up.

  • GSK plans $1 mln prize to jump-start "electroceuticals" Wednesday, 10 Apr 2013 | 1:00 PM ET

    LONDON, April 10- GlaxoSmithKline, Britain's biggest drugmaker, is placing a small but important bet on a new way of treating diseases by targeting electrical signals in the body.

  • April 10- St. Jude Medical Inc said on Wednesday it received European regulatory approval for a brain implant used to treat primary and secondary Dystonia, a neurological movement disorder.